Disease Info Card

Gilbert Disease (disorder)

Information about Gilbert Disease (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Gilbert Disease (disorder)

Most recent studies have shown that Gilbert Disease (disorder) shares some biological mechanisms with anemia, anemia-hemolytic, cholecystolithiasis, cholelithiasis, cholestasis, crigler-najjar-syndrome, glucosephosphate-dehydrogenase-deficiency, hemolysis-(disorder), hepatitis, hyperbilirubinemia, hyperbilirubinemia-hereditary, hyperbilirubinemia-neonatal, icterus, jaundice-chronic-idiopathic, kernicterus, liver-cirrhosis, liver-diseases, malignant-neoplasms, neonatal-jaundice, unconjugated-hyperbilirubinemia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Gilbert Disease (disorder), and have been seen in publications frequently: Anion Transport, Bilirubin Conjugation, Bilirubin Transport, Coagulation, Conjugation, Dna Protection, Excretion, Gallstone Formation, Gliogenesis, Hypersensitivity, Inflammatory Response, Localization, Neurogenesis, Nuclear Export, Organic Anion Transport, Pathogenesis, Pigmentation, Secretion, Transport, Vasodilation

Quite a number of genes have been found to play important roles in Gilbert Disease (disorder), such as ABCC2, ALB, APC, G6PD, GGT1, GLUL, HMOX1, IBSP, SLC17A5, SLC35A2, SLC45A2, UBL4A, UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A6, UGT1A9. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.